Is it time for a paradigm shift: Should double-lung transplant be considered the treatment of choice for idiopathic pulmonary arterial hypertension and giant pulmonary aneurysm?
Stefano PelenghiCristiano PrimiceriMirko BelliatoStefano GhioLaura ScelsiPasquale TotaroPublished in: Journal of cardiac surgery (2021)
Idiopathic pulmonary arterial hypertension is a rare condition, frequently complicated by pulmonary arteries' aneurysm. Aggressive medical therapy is often unsatisfactory and lung transplantation remains the only option. We report a unique case of severe idiopathic pulmonary arterial hypertension complicated by a giant pulmonary aneurism, massive pulmonary valve regurgitation, and right ventricle dysfunction. The patient was, as our first choice, listed for heart-lung transplantation and remained in emergency list for more than 7 months. Unfortunately, due to further clinical deterioration and the unavailability of a heart-lung bloc, plan B was mandatory. The patient underwent a combined procedure including: double lung transplant, pulmonary artery plasty, and sutureless pulmonary valve prosthesis with open deployment (first-in-man use in such scenario). Postoperative outcome was uneventful. Our thought is that double lung transplantation and conventional combined pulmonary artery/valve surgery should be considered as the first option avoiding excessive waiting times and potential further clinical deterioration.
Keyphrases
- pulmonary arterial hypertension
- pulmonary hypertension
- pulmonary artery
- aortic valve
- coronary artery
- minimally invasive
- mitral valve
- heart failure
- case report
- healthcare
- public health
- emergency department
- physical activity
- aortic stenosis
- oxidative stress
- atrial fibrillation
- mesenchymal stem cells
- body mass index
- risk assessment
- acute coronary syndrome
- percutaneous coronary intervention
- early onset
- coronary artery bypass
- transcatheter aortic valve replacement
- drug induced